First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers. . . . → Read More: Trial Shows Immunotherapies Extend Life with Melanoma
|
|||||
|
|
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing 
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds 
A new enterprise based on psychiatric and molecular research at Indiana University is developing precision-medicine diagnostics for pain and mental disease. . . . → Read More: Start-Up Creating Blood Tests, Apps for Mental Disorders
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds  One comment - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, Japan, licensing, manufacturing, pharmaceuticals, stem cells, university, venture capital 
Researchers in Germany are developing techniques with artificial DNA and hydrogel designed to control the sequence of drugs delivered into the body. . . . → Read More: Artificial DNA Designed to Control Drug Delivery Comments are closed New products biomedical, biotechnology, chemistry, engineering, Europe, genomics, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, university 
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, investment, IPO, life sciences, mathematics, medical device, pharmaceuticals, physical sciences 
An analysis of gut microbes from elite athletes identified a particular bacterial strain, which in tests with lab mice boosted their exercise endurance. . . . → Read More: Gut Microbe Linked to Longer Exercise Endurance Comments are closed New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
A health care network in Utah is partnering with a genetic analytics company to find connections between genetics and disease in 500,000 of its members. . . . → Read More: Intermountain, deCode Partner on Population Genetics Comments are closed Joint ventures/collaborations biomedical, clinical trials, Europe, genomics, life sciences, mathematics, medical device 
A small patch with tiny needles collects DNA from leaves in about one minute, making possible portable devices to detect plant diseases. . . . → Read More: Patch Performs Fast DNA Collection for Plant Diseases |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||